SCHEMBL4579310

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3152430	0.89	KDR (0.80)	KDREGFRRETFGFR1FLT1
	SCHEMBL4578369	0.89	EGFR (0.65)	KDREGFRRETFGFR1FLT1
	SCHEMBL5509723	0.88	EGFR (0.71)	KDREGFRRETFGFR1FLT1
	SCHEMBL5511525	0.88	KDR (0.67)	KDREGFRRETFGFR1FLT1
	SCHEMBL4578566	0.87	KDR (0.64)	KDREGFRRETFGFR1FLT1
	SCHEMBL4577855	0.86	EGFR (0.89)	KDREGFR
	SCHEMBL5505208	0.83	EGFR (0.66)	KDREGFRRETFGFR1FLT1
	SCHEMBL5091140	0.83	KDR (0.74)	KDREGFRRETFGFR1FLT1
	SCHEMBL4578362	0.82	EGFR (0.66)	KDREGFRRETFGFR1FLT1
	SCHEMBL5514909	0.82	EGFR (0.72)	KDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.